UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000054931
Receipt number R000062648
Scientific Title Investigation of Factors Associated with Time to Obstruction or Migration of Self-Expandable Metallic Stents in Distal Malignant Biliary Obstruction
Date of disclosure of the study information 2024/07/20
Last modified on 2024/07/10 19:12:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of Factors Associated with Time to Obstruction or Migration of Self-Expandable Metallic Stents in Distal Malignant Biliary Obstruction

Acronym

Investigation of Factors of TRBO of SEMS in Distal Malignant Biliary Obstruction

Scientific Title

Investigation of Factors Associated with Time to Obstruction or Migration of Self-Expandable Metallic Stents in Distal Malignant Biliary Obstruction

Scientific Title:Acronym

Investigation of Factors of TRBO of SEMS in Distal Malignant Biliary Obstruction

Region

Japan


Condition

Condition

distal malignant biliary obstruction

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Patients with distal malignant biliary obstruction (DMBO) often experience recurrent biliary obstruction (RBO) after self-expandable metallic stent (SEMS) placement. Factors related to the time to RBO (TRBO) vary across reports and are not well understood. This study aims to identify TRBO-related factors to inform stent treatment strategies.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

TRBO-related factors

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

This study included patients who underwent endoscopic retrograde cholangiopancreatography (ERCP) for DMBO at our hospital from January 2016 to June 2023 and underwent their first SEMS placement.

Key exclusion criteria

Patients in whom SEMS were placed using percutaneous transhepatic biliary drainage or endoscopic ultrasound-guided biliary drainage were excluded.

Target sample size

119


Research contact person

Name of lead principal investigator

1st name Junichiro
Middle name
Last name Kumagai

Organization

Kimitsu Chuo Hospital

Division name

Department of Gastroenterology

Zip code

2928535

Address

1010 Sakurai, Kisarazu, Chiba

TEL

0438361071

Email

kuma920jun@yahoo.co.jp


Public contact

Name of contact person

1st name Junichiro
Middle name
Last name Kumagai

Organization

Kimitsu Chuo Hospital

Division name

Department of Gastroenterology

Zip code

2928535

Address

1010 Sakurai, Kisarazu, Chiba

TEL

0438361071

Homepage URL


Email

kuma920jun@yahoo.co.jp


Sponsor or person

Institute

Kimitsu Chuo Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kimitsu Chuo Hospital

Address

1010 Sakurai, Kisarazu, Chiba

Tel

0438361071

Email

kuma920jun@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 07 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

119

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 01 Month 01 Day

Date of IRB

2024 Year 07 Month 10 Day

Anticipated trial start date

2016 Year 01 Month 01 Day

Last follow-up date

2023 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Patients who underwent endoscopic retrograde cholangiopancreatography for distal malignant biliary obstruction and had their first transpapillary self-expandable metallic stent placement at our institution from January 2016 to June 2023 were retrospectively reviewed.


Management information

Registered date

2024 Year 07 Month 10 Day

Last modified on

2024 Year 07 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000062648


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name